Federated Hermes, Inc. Corcept Therapeutics Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 6,698 shares of CORT stock, worth $374,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,698

Previous 38,759 82.72%

Holding current value

$374,552

Previous $1.26 Million 75.46%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$29.51 - $46.26 $946,120 - $1.48 Million	-32,061 Reduced 82.72%	6,698 $309,000
Q2 2024 Aug 08, 2024	SELL	$22.21 - $34.48 $247,574 - $384,348	-11,147 Reduced 22.34%	38,759 $1.26 Million
Q1 2024 May 14, 2024	SELL	$21.1 - $27.46 $34.6 Million - $45 Million	-1,639,823 Reduced 97.05%	49,906 $1.26 Million
Q4 2023 Jan 31, 2024	SELL	$24.82 - $32.88 $40,828 - $54,087	-1,645 Reduced 0.1%	1,689,729 $54.9 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $23.5 Million - $36.1 Million	-1,068,922 Reduced 38.72%	1,691,374 $46.1 Million
Q1 2023 May 08, 2023	SELL	$19.2 - $24.47 $9.82 Million - $12.5 Million	-511,579 Reduced 15.64%	2,760,296 $59.8 Million
Q4 2022 Feb 13, 2023	SELL	$19.95 - $29.96 $45.5 Million - $68.3 Million	-2,278,925 Reduced 41.06%	3,271,875 $66.5 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $340,860 - $401,856	13,800 Added 0.25%	5,550,800 $142 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $13.8 Million - $20.2 Million	796,580 Added 16.8%	5,537,000 $132 Million
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $1.89 Million - $2.89 Million	114,571 Added 2.48%	4,740,420 $107 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $13.1 Million - $17.9 Million	764,849 Added 19.81%	4,625,849 $91.6 Million
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $23.9 Million - $27.4 Million	-1,215,507 Reduced 23.94%	3,861,000 $76 Million
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $2.03 Million - $3.3 Million	-120,706 Reduced 2.32%	5,076,507 $133 Million
Q3 2020 Nov 12, 2020	BUY	$12.46 - $19.98 $1.28 Million - $2.06 Million	103,032 Added 2.02%	5,197,213 $90.5 Million
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $1.35 Million - $2.24 Million	-122,651 Reduced 2.35%	5,094,181 $85.7 Million
Q1 2020 May 13, 2020	SELL	$10.11 - $14.04 $37 Million - $51.4 Million	-3,657,568 Reduced 41.21%	5,216,832 $62 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $4.43 Million - $6.23 Million	-367,300 Reduced 3.97%	8,874,400 $107 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $10.7 Million - $15.1 Million	-1,028,392 Reduced 10.01%	9,241,700 $131 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $8.86 Million - $11.6 Million	-906,189 Reduced 8.11%	10,270,092 $115 Million
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $4.3 Million - $6.73 Million	-428,508 Reduced 3.69%	11,176,281 $131 Million
Q4 2018 Feb 13, 2019	SELL	$11.29 - $17.19 $5.48 Million - $8.34 Million	-485,031 Reduced 4.01%	11,604,789 $155 Million
Q3 2018 Nov 13, 2018	BUY	$12.27 - $15.65 $2.08 Million - $2.66 Million	169,712 Added 1.42%	12,089,820 $169 Million
Q2 2018 Aug 10, 2018	SELL	$15.3 - $19.69 $11.7 Million - $15.1 Million	-766,619 Reduced 6.04%	11,920,108 $187 Million
Q1 2018 May 09, 2018	BUY	$14.59 - $25.5 $915,011 - $1.6 Million	62,715 Added 0.5%	12,686,727 $209 Million
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $11.2 Million - $14.7 Million	708,219 Added 5.94%	12,624,012 $0
Q3 2017 Nov 13, 2017	BUY	$12.3 - $19.3 $147 Million - $230 Million	11,915,793	11,915,793 $230 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.99B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Corcept Therapeutics Inc Transaction History